glp-1 agonists weight loss drugs market Global Receptor Agonist Size, Forecast Weight-loss drugs such as Ozempic
Description
doi: 10.1016/s0006-8993(97)00190-x
Beejal Vyas-Price of McCann Healthcare, Australia
Lingvay, A
aRR, adjusted relative risk
doi: 10.1111/DOM.14997 31 MaXLiuZIlyasILittlePJKamatoDSahebkaAet al
subsequently confirmed this association in a large multicenter database study of 37.1 million adults, but the incidence was low at 14.5 per 100,000 person-years among semaglutide users, and there was only a modest increase in risk attributable to semaglutide (90)
